Evaluating colitis treatment efficacy and body composition changes using an IL-12/23 p40 neutralizing antibody, measured ...

Dr. Raymond Cross of Mercy Medical Center joins Jennifer Franciotti for a conversation about ulcerative colitis - how it ...

Women with ulcerative colitis are three times more likely than men to have proximal constipation. 6 Treatments for Constipation People with UC may find relief through dietary changes, increasing their ...

The U.S. biotech company Spyre Therapeutics announced yesterday that it has dosed the first participants in two Phase 1 ...

Crohn’s and colitis - During Crohn’s and Colitis Awareness Week, organisations from all over the globe come together to raise ...

What is Crohn’s disease? Start the day smarter. Get all the news you need in your inbox each morning. Crohn’s disease is a ...

The preliminary findings revealed that PALI-2108 was safe and well tolerated in the first three cohorts at doses 15 mg, 50 mg, and 150 mg. It also demonstrated delayed release of PDE4 inhibitor active ...

Learn about the new guidelines released by the AGA for pharmacological management of moderate-to-severe ulcerative colitis.

The chronic condition can cause abdominal pain, diarrhea, bloody stools and fatigue. New research suggests it affects more ...

Crohn’s and Colitis affect over 500,000 people in the UK, significantly impacting their health, daily lives, and wellbeing. Despite progress in awareness and treatment, we know many people with ...

Everest Medicines announces acceptance of Velsipity NDA in Hong Kong to treat moderately to severely active ulcerative colitis: Shanghai, China Tuesday, December 3, 2024, 10:00 Hr ...